Acrivon Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $16k | 8.7k | 1.81 |
| 2025-06-30 | $11k | 8.8k | 1.19 |
| 2025-03-31 | $6.3k | 3.1k | 2.03 |
| 2024-12-31 | $11k | 1.8k | 6.02 |
| 2024-09-30 | $33k | 4.8k | 7.00 |
| 2024-06-30 | $22k | 3.8k | 5.80 |
| 2024-03-31 | $5.8k | 817 | 7.15 |
| 2023-09-30 | $12k | 1.3k | 9.56 |
| 2023-06-30 | $9.5k | 732 | 12.96 |
| 2023-03-31 | $14k | 1.1k | 12.82 |
| 2022-12-31 | $2.0k | 159 | 12.58 |